XILONG SCIENTIFIC(SZ:002584) Xin Lang Zheng Quan·2025-10-31 09:14Core Insights - Xilong Science is a leading domestic chemical reagent company with a full industry chain advantage, highlighting its investment value [1] Group 1: Financial Performance - In Q3 2025, Xilong Science achieved a revenue of 5.324 billion, ranking first among 35 companies in the industry, while the industry average was 1.399 billion [2] - The net profit for the same period was -60.94 million, placing it last in the industry, with the industry average net profit at 155 million [2] Group 2: Financial Ratios - As of Q3 2025, Xilong Science's debt-to-asset ratio was 56.30%, higher than the previous year's 53.08% and the industry average of 28.64% [3] - The gross profit margin for Q3 2025 was 7.52%, which, although an increase from 6.81% year-on-year, remained below the industry average of 31.60% [3] Group 3: Executive Compensation - The chairman, Huang Shaoqun, received a salary of 420,000, unchanged from 2023, while the president, Zhao Ye, saw an increase in salary to 623,700 from 499,900, reflecting a rise of 123,800 [4] Group 4: Shareholder Information - As of September 30, 2025, the number of A-share shareholders decreased by 2.33% to 85,100, while the average number of circulating A-shares held per shareholder increased by 2.38% to 5,503.91 [5]